Naturally acquired Rift Valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein

Naturally acquired Rift Valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein

Rift Valley fever (RVF) is a viral hemorrhagic disease first discovered in Kenya in 1930. Numerous animal studies have demonstrated that protective immunity is acquired following RVF virus (RVFV) infection and that this correlates with acquisition of virus-neutralizing antibodies (nAbs) that target...

Descripció completa

Dades bibliogràfiques
Autors principals:	Wright, D, Allen, ER, Clark, MHA, Gitonga, JN, Karanja, HK, Hulswit, RJG, Taylor, I, Biswas, S, Marshall, J, Mwololo, D, Muriuki, J, Bett, B, Bowden, TA, Warimwe, GM
Format:	Journal article
Idioma:	English
Publicat:	Cell Press 2020

Ítems similars

Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein
per: Daniel Wright, et al.
Publicat: (2020-11-01)

Rift Valley fever: biology and epidemiology
per: Wright, D, et al.
Publicat: (2019)

Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers.
per: Huiskonen, J, et al.
Publicat: (2009)

Two monoclonal antibodies against glycoprotein Gn protect mice from Rift Valley Fever challenge by cooperative effects.
per: Benjamin Gutjahr, et al.
Publicat: (2020-03-01)

Vaccine Efficacy of Self-Assembled Multimeric Protein Scaffold Particles Displaying the Glycoprotein Gn Head Domain of Rift Valley Fever Virus
per: Paul J. Wichgers Schreur, et al.
Publicat: (2021-03-01)

N-Glycans on the Rift Valley Fever Virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGN
per: Inaia Phoenix, et al.
Publicat: (2016-05-01)

Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein
per: Meng Hao, et al.
Publicat: (2020-02-01)

What is the potential role of veterinary vaccination in the control of Rift Valley fever in Kenya?
per: Clark, MHA
Publicat: (2020)

Association between Rift Valley fever virus seroprevalences in livestock and humans and their respective intra-cluster correlation coefficients, Tana River County, Kenya
per: Bett, B, et al.
Publicat: (2018)

A protective monoclonal antibody targets a site of vulnerability on the surface of Rift Valley fever virus
per: Allen, ER, et al.
Publicat: (2018)

Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.
per: Nitin Bhardwaj, et al.
Publicat: (2010-06-01)

Clinical manifestations of Rift Valley fever in humans: Systematic review and meta-analysis.
per: Zacchaeus Anywaine, et al.
Publicat: (2022-03-01)

Modelling Vaccination Strategies against Rift Valley Fever in Livestock in Kenya.
per: John M Gachohi, et al.
Publicat: (2016-12-01)

The Jordan Rift Valley /
per: 448285 Horowitz, Aharon
Publicat: (2001)

An XGBoost Approach to Predictive Modelling of Rift Valley Fever Outbreaks in Kenya Using Climatic Factors
per: Damaris Mulwa, et al.
Publicat: (2024-10-01)

Pastoralists' perceptions on the impact of Rift valley fever disease following an outbreak in North Eastern Kenya
per: Caroline M. Mburu, et al.
Publicat: (2022-06-01)

Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses
per: Nathaniel S. Chapman, et al.
Publicat: (2023-09-01)

Rift valley : Afro-Arabian /
per: Quennell, A. M.
Publicat: (1982)

The Pathogenesis of Rift Valley Fever
per: Tetsuro Ikegami, et al.
Publicat: (2011-05-01)

Rift Valley Fever Encephalitis
per: Abdulrahman A. Alrajhi, et al.
Publicat: (2004-03-01)

The Rift Valley fever accessory proteins NSm and P78/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts
per: Felix Kreher, et al.
Publicat: (2014-01-01)

Bacterium-Like Particles Displaying the Rift Valley Fever Virus Gn Head Protein Induces Efficacious Immune Responses in Immunized Mice
per: Shengnan Zhang, et al.
Publicat: (2022-03-01)

Recent Advances in Bunyavirus Glycoprotein Research: Precursor Processing, Receptor Binding and Structure
per: Ruben J. G. Hulswit, et al.
Publicat: (2021-02-01)

Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
per: Busquets, N, et al.
Publicat: (2014)

Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs
per: Busquets, N, et al.
Publicat: (2014)

Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein
per: Claudia Gandolfo, et al.
Publicat: (2021-08-01)

Fine epitope mapping of glycoprotein Gn in Guertu virus.
per: Jingyuan Zhang, et al.
Publicat: (2019-01-01)

A systematic review of Rift Valley Fever epidemiology 1931–2014
per: Mark O. Nanyingi, et al.
Publicat: (2015-07-01)

Spatial and temporal pattern of Rift Valley fever outbreaks in Tanzania; 1930 to 2007.
per: Calvin Sindato, et al.
Publicat: (2014-01-01)

Systematic literature review of Rift Valley fever virus seroprevalence in livestock, wildlife and humans in Africa from 1968 to 2016
per: Clark, M, et al.
Publicat: (2018)

Predictive Factors and Risk Mapping for Rift Valley Fever Epidemics in Kenya.
per: Peninah M Munyua, et al.
Publicat: (2016-01-01)

Seroepidemiology of Rift Valley Fever in Basrah
per: Rahman Kadhum Muhsen
Publicat: (2012-12-01)

An epidemiological model of Rift Valley fever
per: Nicole P. Leahy, et al.
Publicat: (2007-08-01)

Genomic surveillance of Rift Valley fever virus: from sequencing to lineage assignment
per: John Juma, et al.
Publicat: (2022-07-01)

Dynamic risk model for Rift Valley fever outbreaks in Kenya based on climate and disease outbreak data
per: David Gikungu, et al.
Publicat: (2016-05-01)

"Without a man's decision, nothing works": Building resilience to Rift Valley fever in pastoralist communities in Isiolo Kenya.
per: Irene N Mutambo, et al.
Publicat: (2025-01-01)

Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells.
per: Hana M Weingartl, et al.
Publicat: (2014-01-01)

An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep
per: Abdelrahman Said, et al.
Publicat: (2017-08-01)

Chimpanzee adenovirus vaccine provides multispecies protection against Rift Valley Fever
per: Warimwe, G, et al.
Publicat: (2016)

Postharvest Storage Practices of Maize in Rift Valley and Lower Eastern Regions of Kenya: A Cross-Sectional Study
per: Peter Koskei, et al.
Publicat: (2020-01-01)